Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Breast Neoplasms 40Rectal Neoplasms 21Colorectal Neoplasms 20Colonic Neoplasms 19Glioblastoma 13Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 11Gliosarcoma 11Central Nervous System Neoplasms 11Esophageal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Adenocarcinoma Of Esophagus 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Ovarian Neoplasms 6Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 6Breast Neoplasms, Male 6Melanoma 5Esophageal Squamous Cell Carcinoma 5Breast Carcinoma In Situ 5Salivary Gland Neoplasms 4Nasopharyngeal Carcinoma 4Lymphoma 4Fallopian Tube Neoplasms 4

Interventions

Cyclophosphamide 297Rituximab 272Etoposide 149Filgrastim 142fludarabine phosphate 120Cytarabine 109Vincristine 107Melphalan 102Radiotherapy 101Doxorubicin 97Peripheral Blood Stem Cell Transplantation 93Methotrexate 91fludarabine 86Prednisone 86Busulfan 86Tacrolimus 66Mycophenolic Acid 62Granulocyte Colony-Stimulating Factor 60Antilymphocyte Serum 58Dexamethasone 57Whole-Body Irradiation 55Carmustine 54Bortezomib 45Cyclosporine 44Lenalidomide 41Methylprednisolone 40sargramostim 39Bendamustine Hydrochloride 37ibritumomab tiuxetan 34Ifosfamide 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Lymphoma × Chemotherapy, Adjuvant × Clear all
NCT00006478 2023-09-18

Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma

University of Nebraska

Phase 2 Terminated
19 enrolled 4 charts
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00478062 2018-02-28

Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Terminated
1 enrolled 3 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT00242996 2017-09-28

Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
44 enrolled
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00012207 2010-08-24

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Fred Hutchinson Cancer Center

Phase 1 Completed
12 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡